Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GVB-2020
- Development stage
- Preclinical
- Lead developer
- Genvira Biosciences
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Administration
- Intravenous
01
Overview
GVB-2020 is an experimental in vivo gene therapy being developed by Genvira Biosciences for the treatment of various cancers. The therapy utilizes a viral vector platform designed to target T cells directly within the patient's body (in vivo), bypassing the complex and costly ex vivo manufacturing processes associated with traditional CAR-T therapies. GVB-2020 delivers payloads consisting of chimeric antigen receptor (CAR) or T-cell receptor (TCR) constructs, along with cytokines, to reprogram the immune system in situ and generate anti-tumor activity. Additionally, the platform incorporates genome editing capabilities to further modify the T cells within the patient. As of early 2024, the program is in preclinical development and has demonstrated validation in cell-based models.
Beyond the preview
Go deeper on GVB-2020.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GVB-2020.